Eucalyptus Oil

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity inflammation pain

Research Overview

Across the studies reviewed here, eucalyptus oil research is most concentrated in two applied areas: (1) vector control and bite prevention, and (2) topical antimicrobial and wound-healing applications, often using advanced delivery systems. In public health prevention, oil of lemon eucalyptus is discussed alongside other EPA-registered insect repellent actives as an established alternative of interest with efficacy in some contexts comparable to DEET. In therapeutics, multiple studies focus on formulating eucalyptus oil into nanoemulsions or lipid nanoparticles to improve stability, skin delivery, and bioactivity, with evaluations spanning in vitro antimicrobial assays (notably against Staphylococcus aureus and Candida albicans) and preclinical wound models in rodents. A smaller, formulation-focused line of work uses eucalyptus oil as an excipient/oil phase in nanoemulsions for non-dermal delivery (e.g., intranasal hypericin nanoemulsion), indicating broader interest in eucalyptus oil as a functional formulation component beyond its intrinsic bioactivity.

The strongest evidence in these studies supports eucalyptus-derived products as (a) effective components of insect repellent strategies (particularly where standardized, regulated actives such as oil of lemon eucalyptus are used), and (b) antimicrobial and wound-healing adjuncts in preclinical settings when delivered via nanoemulsions or lipid nanoparticles. Laboratory findings include rapid bactericidal effects of eucalyptus oil nanoemulsions against S. aureus with microscopy-confirmed membrane damage, and improved wound contraction/epithelialization outcomes in rat models, including infected wounds where mixed-oil formulations containing eucalyptus constituents outperformed eucalyptus oil alone and reduced fungal burden. For vector control, eucalyptus oil nanoemulsions show enhanced larvicidal activity versus bulk emulsions against Culex quinquefasciatus, with associated biochemical and histopathologic changes in larvae, supporting a plausible mechanistic basis for insecticidal action.

Key gaps are the limited amount of high-quality human clinical evidence for therapeutic (non-repellent) uses, and the need for standardization and comparability across studies. Many results are derived from in vitro assays and animal models, and several promising outcomes rely on specific formulations (nanoemulsions, nanoparticles, mixed oils), making it difficult to generalize to commercial products or traditional preparations without controlled head-to-head testing. Further research priorities include: well-designed randomized clinical trials for topical wound and infection indications; rigorous safety/irritation and sensitization assessment across concentrations and formulations; standardized chemical characterization (chemotype, batch variability) linked to bioactivity; and translational studies that compare eucalyptus oil formulations to current standards of care (e.g., established antimicrobials, modern wound dressings) using clinically relevant endpoints.

1. What conditions has Eucalyptus Oil been studied for?

  • Prevention of arthropod bites / vector-borne disease risk reduction (repellency): A review of EPA-registered insect repellents includes oil of lemon eucalyptus among alternatives to DEET for protection against mosquitoes and other arthropods (relevant to diseases transmitted by bites such as malaria, dengue, Zika, West Nile, Lyme).

  • Wound healing (including infected wounds): Multiple studies evaluate eucalyptus oil in topical systems (nanoemulsions, lipid nanoparticles, creams) for wound healing, including Candida albicans–infected wounds in rats and wound models in rats.

  • Antibacterial activity / skin infection contexts: Eucalyptus oil nanoemulsion tested against Staphylococcus aureus (time-kill analysis) and lipid nanoparticle systems evaluated for antimicrobial activity against reference strains (details truncated in abstract).

  • Antifungal activity: Eucalyptus oil (and a mixed-oil formulation containing components including Eucalyptus citriodora-derived constituents) tested against Candida albicans in vitro and in vivo (rat wound model).

  • Mosquito control (larvicidal activity) relevant to filariasis: Eucalyptus oil nanoemulsion tested against Culex quinquefasciatus larvae (vector of filariasis).

  • Tick control (acaricidal/repellent activity): Eucalyptus oil studied against deltamethrin-resistant Rhipicephalus annulatus ticks (adulticidal, larvicidal, ovicidal, repellent activity).

  • Drug delivery/permeation enhancement (formulation science): Eucalyptus oil used as an oil phase or membrane-flexibilizer in delivery systems (e.g., nanoemulsions/nanoemulgels; niosomes for transdermal felodipine; intranasal nanoemulsion for hypericin).

  • Oral health (broad essential-oil literature): A review of essential oils (including eucalyptus oil) discusses potential for oral diseases, while emphasizing need for more clinical trials.

2. Does it work in treating those conditions? Summarize the evidence.

  • Insect repellency (prevention): The insect repellent review states that some EPA-registered alternatives (including oil of lemon eucalyptus) have efficacies comparable to DEET for arthropod protection. This supports effectiveness for bite prevention, but the study does not provide specific trial sizes, effect sizes, or duration of protection.

  • Antibacterial activity (laboratory + animal wound model): In one study, a eucalyptus oil nanoemulsion showed strong antibacterial activity against Staphylococcus aureus by time-kill analysis with complete loss of viability within 15 minutes, with electron microscopy evidence of membrane damage. In the same study, topical use in Wistar rats was reported as non-irritant and associated with a higher wound contraction rate versus control and neomycin-treated rats (per abstract).

  • Antifungal + infected wound healing (animal model): In a rat excision wound model infected with Candida albicans, eucalyptus oil (EO) and a mixed oil (MO) formulation were tested. The MO showed stronger in vitro antifungal activity than EO (reported inhibitory zone 23.4 mm and MIC 0.24 g/mL for MO vs 13.4 mm and 15.63 g/mL for EO). In vivo, MO 10% cream produced the best wound contraction and epithelialization outcomes and reduced fungal load with histopathologic improvement versus negative control. This supports potential benefit, but it is an animal study and the most impressive results were for a mixture rather than eucalyptus oil alone.

  • Mosquito larvicidal activity (vector control): A eucalyptus oil nanoemulsion (stable formulation described; droplet size ~9.4 nm) showed higher larvicidal activity than bulk emulsion against Culex quinquefasciatus. Biochemical assays in larvae showed decreased total protein and significant reduction in acetylcholinesterase and phosphatases, suggesting a plausible toxic mechanism to larvae. This supports vector-control potential, not direct treatment of filariasis in humans.

  • Tick control (acaricidal/ovicidal): Eucalyptus oil showed significant effects on tick adults at concentrations >5%; at 10% it showed 96.7% adulticidal activity and stopped egg hatching in deltamethrin-resistant Rhipicephalus annulatus. This supports acaricidal potential, but it is not evidence of treating human tick-borne disease—rather, it may reduce exposure risk in relevant settings.

  • Wound healing via lipid nanoparticles: A formulation study developed lipid nanoparticles loaded with eucalyptus essential oil and evaluated cytocompatibility, fibroblast proliferation, wound healing properties, and antimicrobial activity against reference strains (details truncated). The study supports active investigation and suggests potential, but does not provide specific quantitative outcomes in the excerpt provided.

  • Oral disease (clinical relevance uncertain from provided text): A review concludes essential oils have potential for prevention/therapy of oral diseases but emphasizes that further clinical trials are required to establish safety and efficacy—so evidence is suggestive but not definitive based on the study.

3. What health benefits does it have?

  • Bite prevention / reduced exposure to vectors: Oil of lemon eucalyptus is highlighted among EPA-registered repellents with potentially DEET-comparable efficacy in some contexts, which may reduce risk of arthropod bites and their sequelae (per the repellent review).

  • Topical antimicrobial activity: Eucalyptus oil nanoemulsion demonstrated rapid killing of Staphylococcus aureus with evidence of bacterial membrane damage.

  • Support of wound repair in animal models: In rats, eucalyptus oil nanoemulsion was reported to be non-irritant and associated with higher wound contraction than control and neomycin-treated groups (per abstract). In Candida-infected wounds, a mixed-oil cream containing eucalyptus-related components improved contraction/epithelialization and reduced fungal burden.

  • Vector control (public health-adjacent benefit): Eucalyptus oil nanoemulsion showed enhanced larvicidal activity against Culex quinquefasciatus, with biochemical evidence consistent with toxicity to larvae (e.g., reduced acetylcholinesterase).

  • Potential role in topical drug delivery systems: Reviews and formulation studies describe eucalyptus oil as an oil phase with anti-inflammatory properties in nanoemulgels and as a membrane-flexibilizer in niosomes to influence transdermal delivery—this is a formulation benefit rather than a proven standalone clinical benefit.

4. Does it have any downsides or side effects?

  • Skin irritation/sensitization risk (general essential oil concern): The oral-disease essential-oil review explicitly discusses adverse effects as part of its scope, implying that side effects exist across essential oils; however, the study text does not list eucalyptus-specific adverse event rates or types.

  • Topical tolerability in one animal study was favorable: The eucalyptus oil nanoemulsion wound-healing study in Wistar rats reported the formulation as non-irritant (helpful but limited—animal data, specific formulation, and short-term observation).

  • Formulation/quality variability: Several studies involve nanoemulsions, lipid nanoparticles, and mixed-oil creams. Benefits and risks may depend heavily on concentration, excipients (e.g., surfactants like Tween 80), and delivery system; the studies do not establish safety for all consumer preparations.

  • Evidence limitations: Much of the efficacy evidence here is in vitro or animal-model based. Human safety and effectiveness for wound treatment or antimicrobial use cannot be assumed from these studies alone.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are reported in the studies reviewed here. None describe outcomes stratified by genotype, nor do they identify genetic variants affecting response, metabolism, efficacy, or adverse effects of eucalyptus oil (or oil of lemon eucalyptus). Based on these studies alone, there is insufficient evidence to claim benefit or harm for any specific genetic variation.

References

  1. Insect repellents: An updated review for the clinician.
    Quoc-Bao D Nguyen, Mai-Anh N Vu, Adelaide A Hebert (2023) - Journal of the American Academy of Dermatology
  2. Essential oil-loaded lipid nanoparticles for wound healing.
    Francesca Saporito, Giuseppina Sandri, Maria Cristina Bonferoni, Silvia Rossi, Cinzia Boselli, Antonia Icaro Cornaglia, Barbara Mannucci, Pietro Grisoli, Barbara Vigani, Franca Ferrari (2018) - International journal of nanomedicine
  3. Ultrasonic emulsification of eucalyptus oil nanoemulsion: antibacterial activity against Staphylococcus aureus and wound healing activity in Wistar rats.
    Saranya Sugumar, Vijayalakshmi Ghosh, M Joyce Nirmala, Amitava Mukherjee, Natarajan Chandrasekaran (2014) - Ultrasonics sonochemistry
  4. Nanoemulsion of eucalyptus oil and its larvicidal activity against Culex quinquefasciatus.
    S Sugumar, S K Clarke, M J Nirmala, B K Tyagi, A Mukherjee, N Chandrasekaran (2014) - Bulletin of entomological research
  5. Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers.
    Muhammad Ahsan Waqar, Muhammad Zaman, Huma Hameed, Muhammad Jamshaid, Ali Irfan, Gamal A Shazly, Ana Cláudia Paiva-Santos, Yousef A Bin Jardan (2023) - ACS omega
  6. Anticandidal effect of Eucalyptus oil and three isolated compounds on cutaneous wound healing in rats.
    M A El-Sakhawy, G A Soliman, H H El-Sheikh, M A Ganaie (2023) - European review for medical and pharmacological sciences
  7. Essential oils, their therapeutic properties, and implication in dentistry: A review.
    Namrata Dagli, Rushabh Dagli, Rasha Said Mahmoud, Kusai Baroudi (2015) - Journal of International Society of Preventive & Community Dentistry
  8. Formulation Development and Ex-Vivo Permeability of Curcumin Hydrogels under the Influence of Natural Chemical Enhancers.
    Asif Nawaz, Arshad Farid, Muhammad Safdar, Muhammad Shahid Latif, Shakira Ghazanfar, Nosheen Akhtar, Soad K Al Jaouni, Samy Selim, Muhammad Waseem Khan (2022) - Gels (Basel, Switzerland)
  9. Toxicity, repellency and anti-cholinesterase activities of thymol-eucalyptus combinations against phenotypically resistant Rhipicephalus annulatus ticks.
    Waleed M Arafa, Shawky M Aboelhadid, Abeer Moawad, Khalid M Shokeir, Osama Ahmed (2020) - Experimental & applied acarology
  10. An Overview of Nanoemulgels for Bioavailability Enhancement in Inflammatory Conditions via Topical Delivery.
    Diwya Kumar Lal, Bhavna Kumar, Abdulaziz S Saeedan, Mohd Nazam Ansari (2023) - Pharmaceutics
  11. Essential oils in niosomes for enhanced transdermal delivery of felodipine.
    Rania K Eid, Ebtessam A Essa, Gamal M El Maghraby (2019) - Pharmaceutical development and technology
  12. Ultrasonic-assisted preparation of eucalyptus oil nanoemulsion: Process optimization, in vitro digestive stability, and anti-Escherichia coli activity.
    Ruiteng Song, Yongqi Lin, Zhenzhen Li (2022) - Ultrasonics sonochemistry
  13. Effect of eucalyptus oil on Streptococcus mutans and Enterococcus faecalis growth.
    Abdulrahman A Balhaddad, Rasha N AlSheikh (2023) - BDJ open
  14. QbD-Based Fabrication of Biomimetic Hydroxyapatite Embedded Gelatin Nanoparticles for Localized Drug Delivery against Deteriorated Arthritic Joint Architecture.
    Qurat Ul Ain, Mahira Zeeshan, Danish Mazhar, Ahmed Zeb, Iqra Afzal, Hameed Ullah, Hussain Ali, Abbas Rahdar, Ana M Díez-Pascual (2024) - Macromolecular bioscience
  15. Nano-Antibacterials Using Medicinal Plant Components: An Overview.
    Sourav Ghosh, Susmita Nandi, Tarakdas Basu (2021) - Frontiers in microbiology
  16. Eucalyptus oil nanoemulsion for enhanced skin deposition of fluticasone propionate in psoriatic plaques: A combinatorial anti-inflammatory effect to suppress implicated cytokines.
    Mohamed Ashraf, Hossam S El-Sawy, Ghada M El Zaafarany, Mona M A Abdel-Mottaleb (2025) - Archiv der Pharmazie
  17. In vitro antiviral activities of thymol and Limonin against influenza a viruses and SARS-CoV-2.
    Gomaa Mostafa-Hedeab, Akram Hegazy, Islam Mostafa, Ibrahim H Eissa, Ahmed M Metwaly, Hany Abdelfattah Elhady, Abozer Y Eledrdery, Sager Holyl Alruwaili, Alaa Oqalaa E Alibrahim, Fawaz O Alenazy, Muhannad Faleh Alanazi Alruwaili, Thamer Alshami Marghel, Muharib Alruwaili, Alaaeldin Mohamed Saad, Mahmoud Bayoumi, Assem Mohamed El-Shazly, Luis Martinez-Sobrido, Ahmed Mostafa (2025) - Scientific reports


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!